Kane Biotech Inc. (TSXV:KNE)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
Jun 10, 2026, 3:44 PM EST
Kane Biotech Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2.22 | -2.72 | 6.17 | -5.27 | -3.82 | -4.85 |
Depreciation & Amortization | 0.13 | 0.16 | 0.22 | 0.24 | 0.26 | 0.19 |
Stock-Based Compensation | -0.21 | -0.08 | 0.71 | 0.44 | 0.28 | 1.09 |
Other Adjustments | 0.44 | 0.16 | -9.9 | 1.99 | 0.5 | -0.01 |
Change in Receivables | 0.17 | 0.05 | 0.02 | 0.01 | 0.28 | 0.04 |
Changes in Inventories | -0.32 | -0.13 | -0.13 | -0.11 | -0.07 | -0.05 |
Changes in Accounts Payable | -0.43 | -0.57 | 0.25 | 0.2 | -0.22 | 0.78 |
Changes in Unearned Revenue | - | - | -0.94 | 0.55 | -0.09 | 0.51 |
Changes in Other Operating Activities | 0.17 | -0.12 | -0.06 | -0.05 | 0.04 | 0.01 |
Operating Cash Flow | -2.64 | -3.26 | -4.11 | -2.08 | -3.04 | -2.29 |
Capital Expenditures | 0.01 | -0 | -0.02 | -0.01 | -0.01 | -0.19 |
Sale of Property, Plant & Equipment | - | 0.06 | - | - | - | - |
Purchases of Intangible Assets | -0.09 | -0.11 | -0.07 | -0.04 | -0.07 | -0.17 |
Proceeds from Business Divestments | - | - | 10.85 | - | - | - |
Other Investing Activities | - | - | -0.49 | 0.83 | -0.02 | -0.02 |
Investing Cash Flow | -0.02 | -0.05 | 10.27 | 0.71 | -0.11 | -0.37 |
Long-Term Debt Issued | 1 | 0.97 | - | 2.01 | 2.78 | 1.8 |
Long-Term Debt Repaid | -0.08 | -0.21 | -6.54 | -0.38 | -0.4 | -0.45 |
Net Long-Term Debt Issued (Repaid) | 0.92 | 0.76 | -6.54 | 1.63 | 2.38 | 1.35 |
Issuance of Common Stock | 1.09 | - | 0.5 | 0.42 | 0.97 | 1.12 |
Net Common Stock Issued (Repurchased) | 1.09 | - | 0.5 | 0.42 | 0.97 | 1.12 |
Other Financing Activities | -0.1 | -0.14 | -0.95 | -0.36 | -0.75 | 0.35 |
Financing Cash Flow | 2.56 | 3.85 | -7.69 | 2.16 | 3.1 | 2.81 |
Net Cash Flow | -0.1 | 0.54 | -1.53 | 0.78 | -0.05 | 0.15 |
Free Cash Flow | -2.63 | -3.26 | -4.14 | -2.09 | -3.05 | -2.48 |
FCF Margin | -4487.53% | -761.99% | -198.77% | -1403.79% | -114.40% | -153.99% |
Free Cash Flow Per Share | -0.01 | -0.02 | -0.03 | -0.02 | -0.03 | -0.02 |
Levered Free Cash Flow | -1.75 | -2.62 | -1.06 | -2.82 | -1.54 | -2.25 |
Unlevered Free Cash Flow | -1.13 | -3.19 | -2.8 | -2.54 | -3.46 | -3.63 |